Latest filing published 25 Aug 2010 for Ernexa Therapeutics Inc., €4,274.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +41.7%Entry US$270,000.00 · Close at T+365 US$382,500.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Mary Beth Lewis: trading record in brief
This profile gathers the share dealings of Mary Beth Lewis in Ernexa Therapeutics Inc. In total, 2 filings cover trades dated from 22 May 2009 to 23 August 2010.
Purchases make up the whole of the open-market record (1 purchase, €2,857). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 1 option exercise.
The record was last updated on 25 August 2010 with an option exercise (€4,274) in Ernexa Therapeutics Inc. The latest purchase dates back some time: it was published 6,375 days ago, on 27 May 2009. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Mary Beth Lewis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 30,000 shares@ US$0.18Common StockSEC:0001019687-10-003182:0
- 10,000 shares@ US$0.40COMMON STOCKSEC:0001019687-09-001962:0Canonical exit: 20 Aug 2009 (T+90)
2 of 2 declarations
